Andreas Harstrick
Chief Executive Officer bei AFFIMED N.V.
Vermögen: 213 765 $ am 31.03.2024
Profil
Andreas Harstrick is currently the Chief Executive & Medical Officer at Affimed NV.
He previously worked as a Director at Lilly Oncology.
From 2008 to 2014, he was the Senior Vice President-Medical Sciences at ImClone LLC.
He also served as the Chief Medical Officer at Molecular Partners AG from 2015 to 2019.
Prior to that, he held the position of SVP-Global Clinical Development Unit Oncology at Merck Serono Ltd.
from 1998 to 2008.
Dr. Harstrick's education includes a doctorate degree from the University of Hannover in 1986.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AFFIMED N.V.
0,27% | 15.03.2023 | 40 333 ( 0,27% ) | 213 765 $ | 31.03.2024 |
Aktive Positionen von Andreas Harstrick
| Unternehmen | Position | Beginn |
|---|---|---|
| AFFIMED N.V. | Chief Executive Officer | 15.01.2024 |
Ehemalige bekannte Positionen von Andreas Harstrick
| Unternehmen | Position | Ende |
|---|---|---|
| MOLECULAR PARTNERS AG | Chief Tech/Sci/R&D Officer | 01.09.2019 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01.01.2014 |
Merck Serono Ltd.
 Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Corporate Officer/Principal | 01.01.2008 |
| University of Duisburg-Essen | Corporate Officer/Principal | - |
Lilly Oncology
 Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Director/Board Member | - |
Ausbildung von Andreas Harstrick
| University of Hannover | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AFFIMED N.V. | Health Technology |
| MOLECULAR PARTNERS AG | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Merck Serono Ltd. provides research and development services and manufactures medicinal drugs. The company is headquartered in Middlesex, the United Kingdom. | Commercial Services |
Lilly Oncology
Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Health Services |
